-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk's Chief Scientific Officer said: We believe the new generation GLP-1 may have differentiated advantages in efficacy, convenience, safety and tolerability.

智通财经·09/21/2026 11:33:12
语音播报
Novo Nordisk's Chief Scientific Officer said: We believe the new generation GLP-1 may have differentiated advantages in efficacy, convenience, safety and tolerability.